Circularity is no longer an ambition for GPE, it is becoming part of how we design, procure and deliver our buildings
— Frank Blande, Head Of Sustainability
”
Great Portland Estates (LSE:GPE), the central London office landlord and developer, told investors it has hosted its first "Seeing is Believing" event at 30 Duke Street in St James's to showcase circular building techniques across its development pipeline.
Today marks a decisive shift by the company as we refocus our core strategy to unlock the value and organic growth potential within our precious and base metals portfolio,
— Cheetham, Executive Chairman
”
Sunrise Resources (AIM:SRES), the AIM-listed exploration company, said it has completed a strategic review that will shift its focus toward its wholly owned precious and base metals projects.
Copper prices remain robust and we have seen only modest cost impacts from the conflicts in the Middle East, therefore our cash position increased materially during the quarter,
— Alberto Lavandeira, Chief Executive
”
Atalaya Mining (LSE:ATYM), the Spain-focused copper producer, reported copper production of 13,493 tonnes for the second quarter, up from 9,939 tonnes in the first quarter and ahead of the 13,175 tonnes produced a year earlier.
We are already gaining volumes in dish and laundry detergent tablets in North America
— John R. Shaw, CEO
”
Itaconix (AIM:ITX) has secured its first customer supply agreement for its 8-gram plastic-free dish detergent tablet, marking a commercial milestone for the plant-based specialty polymer maker.
Achieving sustained production and consistent product quality is a significant milestone
— Kris Andersson, Chief Executive
”
Ironveld (AIM:IRON), the AIM-listed mining development company producing strategic metals for mineral processing applications, said its DMS plant has entered sustained production.
AstraZeneca is a leader in treating EGFR-mutated lung cancer, and we are eager to add Zegfrovy to our world-class portfolio
— Dave Fredrickson, President, Oncology Haematology.
”
AstraZeneca (LSE:AZN) has entered an exclusive worldwide licensing agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), an oral EGFR inhibitor already approved in the US and China for a form of lung cancer.
It is encouraging to see the orebody thicken and show its copper mineralisation as we head into the more central area of Speaks / Mine Club,
— Richard Lloyd, Chief Executive
”
Shuka Minerals (AIM:SKA), the African-focused mine operator and developer, said its eighth drill hole at the Kabwe Zinc Mine has returned copper grades of up to 3% alongside high-grade zinc mineralisation.
This application is consistent with the current New Zealand Government's policy direction to support domestic gas supply and energy security
— Andy Butler, Chief Executive
”
Sunda Energy (AIM:SNDA), the AIM-quoted exploration and appraisal company focused on gas assets in the Asia-Pacific region, has applied for a new Petroleum Exploration Permit in the offshore Taranaki Basin on the west coast of New Zealand's North Island.
There are grounds for optimism, growing recognition of Bleepa at all levels of the NHS
— Tom Oakley, Chief Executive, Bleepa
”
Feedback (AIM:FDBK) reported flat revenue of approximately £0.8m for the year ended 31 May, against £0.9m in the prior year, in an unaudited trading update.
As we continue to accelerate the adoption of our pharmacogenetic tests in the UK and internationally, Graham's strategic expertise and guidance will be integral to the Board,
— Gino Miele, Chief Executive, Genedrive.
”
Genedrive (AIM:GDR), the AIM-listed point of care pharmacogenetic testing company, said Graham Cole CBE has joined its board as Chair and independent Non-Executive Director with immediate effect.
Corporate governance and funding dominated the health and bio space, with a fundraise from Poolbeg Pharma and boardroom changes at genedrive and Spire Healthcare framing the session.
